Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN.

Krebs CF, Kapffer S, Paust HJ, Schmidt T, Bennstein SB, Peters A, Stege G, Brix SR, Meyer-Schwesinger C, Müller RU, Turner JE, Steinmetz OM, Wolf G, Stahl RA, Panzer U.

J Am Soc Nephrol. 2013 Dec;24(12):1955-65. doi: 10.1681/ASN.2013020130. Epub 2013 Aug 15.

2.

Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis.

Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U.

Kidney Int. 2012 Jul;82(1):72-83. doi: 10.1038/ki.2012.101. Epub 2012 Apr 11.

3.

IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases.

Riedel JH, Paust HJ, Krohn S, Turner JE, Kluger MA, Steinmetz OM, Krebs CF, Stahl RA, Panzer U.

J Am Soc Nephrol. 2016 Dec;27(12):3666-3677. Epub 2016 Mar 30.

4.

Stat3 programs Th17-specific regulatory T cells to control GN.

Kluger MA, Luig M, Wegscheid C, Goerke B, Paust HJ, Brix SR, Yan I, Mittrücker HW, Hagl B, Renner ED, Tiegs G, Wiech T, Stahl RA, Panzer U, Steinmetz OM.

J Am Soc Nephrol. 2014 Jun;25(6):1291-302. doi: 10.1681/ASN.2013080904. Epub 2014 Feb 7.

5.

The Th17-defining transcription factor RORγt promotes glomerulonephritis.

Steinmetz OM, Summers SA, Gan PY, Semple T, Holdsworth SR, Kitching AR.

J Am Soc Nephrol. 2011 Mar;22(3):472-83. doi: 10.1681/ASN.2010040435. Epub 2010 Dec 23.

6.

TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis.

Hünemörder S, Treder J, Ahrens S, Schumacher V, Paust HJ, Menter T, Matthys P, Kamradt T, Meyer-Schwesinger C, Panzer U, Hopfer H, Mittrücker HW.

J Pathol. 2015 Sep;237(1):62-71. doi: 10.1002/path.4559. Epub 2015 Jun 11.

PMID:
25965582
7.

Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis.

Li S, Kurts C, Köntgen F, Holdsworth SR, Tipping PG.

J Exp Med. 1998 Aug 3;188(3):597-602.

8.

Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis.

Summers SA, Phoon RK, Odobasic D, Dewage L, Kitching AR, Holdsworth SR.

Clin Exp Immunol. 2011 Nov;166(2):227-34. doi: 10.1111/j.1365-2249.2011.04437.x.

9.

CXCL5 drives neutrophil recruitment in TH17-mediated GN.

Disteldorf EM, Krebs CF, Paust HJ, Turner JE, Nouailles G, Tittel A, Meyer-Schwesinger C, Stege G, Brix S, Velden J, Wiech T, Helmchen U, Steinmetz OM, Peters A, Bennstein SB, Kaffke A, Llanto C, Lira SA, Mittrücker HW, Stahl RA, Kurts C, Kaufmann SH, Panzer U.

J Am Soc Nephrol. 2015 Jan;26(1):55-66. doi: 10.1681/ASN.2013101061. Epub 2014 Jun 5.

10.

A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.

Timoshanko JR, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2006 Jan;17(1):150-9. Epub 2005 Nov 30.

11.

CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis.

Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, Wegscheid C, Velden J, Fehr S, Mittrücker HW, Tiegs G, Stahl RA, Panzer U.

J Am Soc Nephrol. 2010 Jun;21(6):974-85. doi: 10.1681/ASN.2009070741. Epub 2010 Mar 18.

12.

MicroRNA-155 a new therapeutic target in crescentic GN.

Holdsworth SR, Summers SA.

J Am Soc Nephrol. 2013 Dec;24(12):1927-9. doi: 10.1681/ASN.2013090924. Epub 2013 Oct 24. No abstract available.

13.

The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis.

Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F, Hölscher C, Wolf G, Kurts C, Mittrücker HW, Stahl RA, Panzer U.

J Am Soc Nephrol. 2009 May;20(5):969-79. doi: 10.1681/ASN.2008050556. Epub 2009 Apr 1.

14.

Regulatory T cell-derived IL-10 ameliorates crescentic GN.

Ostmann A, Paust HJ, Panzer U, Wegscheid C, Kapffer S, Huber S, Flavell RA, Erhardt A, Tiegs G.

J Am Soc Nephrol. 2013 May;24(6):930-42. doi: 10.1681/ASN.2012070684. Epub 2013 May 2.

15.

T cells in crescentic glomerulonephritis.

Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2006 May;17(5):1253-63. Epub 2006 Apr 19.

16.

Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis.

Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL, Akiba H, Yagita H, Holdsworth SR, Kitching AR.

Kidney Int. 2012 May;81(9):844-55. doi: 10.1038/ki.2011.424. Epub 2011 Dec 28.

17.

IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN.

Turner JE, Krebs C, Tittel AP, Paust HJ, Meyer-Schwesinger C, Bennstein SB, Steinmetz OM, Prinz I, Magnus T, Korn T, Stahl RA, Kurts C, Panzer U.

J Am Soc Nephrol. 2012 Sep;23(9):1486-95. doi: 10.1681/ASN.2012010040. Epub 2012 Jul 12.

18.

Interleukin-12 from intrinsic cells is an effector of renal injury in crescentic glomerulonephritis.

Timoshanko JR, Kitching AR, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2001 Mar;12(3):464-71.

19.

Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis.

Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2003 Jul;14(7):1785-93.

20.

IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis.

Kitching AR, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 1999 Apr;10(4):752-9.

Supplemental Content

Support Center